Clinical Trial Update: The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating clevidipine for effects on intracranial pressure and cerebral perfusion pressure in brain-injured patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Traumatic Brain Injury

Drugs mentioned

• clevidipine (clevidipine)

Snippet

Sponsor: Columbia University | Conditions: Hypertension | Phase 4 | Status: WITHDRAWN